Patent · US Active

Anticoagulant antagonist and hemophilia procoagulant

US9241958B2 · kind B2 · utility

2Cited by

57References

12Claims

0Family size

Assignee

The Board of Trustees of the University of Illinois · US

Inventors

Stephanie A. Smith · Champaign, US
James H. Morrissey · Oklahoma City, US

Key dates

Filing date	Jan 30, 2014
Grant date	Jan 26, 2016
Priority date	—
Expiry date	Jan 30, 2034

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/86
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for treating a coagulation deficient patient comprises administering an amount of polyP to the patient sufficient to reduce the PT Test value or Dilute PT Test value of the plasma of the patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.